Bilski: what next for life sciences
Jeffrey Whittle, Michael Samardzija and Michael Hay analyse the Bilski decision from a life sciences perspective, and argue it is a victory for these industries
Wasting little time and with the ink barely dry on the
Bilski v Kappos
opinion, the Supreme Court on Tuesday followed that decision with an answer in the eagerly awaited matter of
Mayo v Prometheus
. The Court granted
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.